Exagen appoints Jeffrey Black as CFO effective Sept 1, John Aballi interim CFO

EXAGEN INC.

Kamal Adawi terminated as CFO and Corporate Secretary effective August 1, 2024.
John Aballi named interim CFO and principal financial officer pending Black's start.
Jeffrey Black to become CFO on Sept 1, 2024; base salary $460K, signing bonus $125K.
Black receives RSUs for 225,000 shares vesting over 4 years, target bonus 50% of salary.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey Black

Chief Financial Officer

XGN · EXAGEN INC.

Effective: 2024-09-01
Filed: August 2, 2024, 7:59 PM ET

On July 25, 2024, the Company appointed, effective as of September 1, 2024, Jeffrey Black to serve as the Company’s Chief Financial Officer and principal financial officer for SEC reporting purposes.

Departed

Kamal Adawi

Chief Financial Officer and Corporate Secretary

XGN · EXAGEN INC.

Effective: 2024-08-01
Successor: John Aballi
Filed: August 2, 2024, 7:59 PM ET

replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.

Appointed (interim)

John Aballi

Interim Chief Financial Officer

XGN · EXAGEN INC.

Effective: 2024-08-01
Filed: August 2, 2024, 7:59 PM ET

the Company also announced that John Aballi had been appointed as Interim Chief Financial Officer of the Company, replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Black was appointed as Chief Financial Officer at EXAGEN INC..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 25, 2024, the Company appointed, effective as of September 1, 2024, Jeffrey Black to serve as the Company’s Chief Financial Officer and principal financial officer for SEC reporting purposes.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kamal Adawi departed as Chief Financial Officer and Corporate Secretary at EXAGEN INC..

Action: no longer serves
Role: Chief Financial Officer and Corporate Secretary

Exact text from the filing

replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

John Aballi was appointed as Interim Chief Financial Officer at EXAGEN INC..

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

the Company also announced that John Aballi had been appointed as Interim Chief Financial Officer of the Company, replacing Kamal Adawi who no longer serves as Chief Financial Officer and Corporate Secretary of the Company, effective as of August 1, 2024.

View on SEC.gov

EXAGEN INC. filing history →

Source: SEC EDGAR

accession 0001274737-24-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.